TrialHuman vaccines & immunotherapeutics2018
Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.
Daniel Cowley et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it